baber/WOPTO huggingface dataset:
Patent NZ-517426-A (NZ)
Title: Phosphate mimics and methods of treatment using phosphatase inhibitors
Inventor: HUANG PING
IPC: A61P3/10
Filed: 2000-08-25
Abstract: Compounds of formula (I), (II) or (III), wherein: Q is CF3SO2, CF3SO2NR3, CF3SO2R4 or CF3SO2N(R3)R4, B is an optionally substituted aryl, carbocyclic, heteroaryl, heterocyclic or phenyl ring, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments to inhibit, regulate or modulate the activity of a phosphate binding protein in a cell.
Patent NZ-518768-A (NZ)
Title: Glass-faced foam laminate architectural panels
Inventor: LEACH ROGER JOHN
IPC: B29C39/38
Filed: 2000-10-09
Abstract: A glass faced architectural panel is described wherein an element that includes a glass sheet (1) for facing the panel is backed by a body of plastics foam (2) and a further item (4) is bonded to the foam body as a backing to it. The degree of foaming within the body increases away from the interface (3) with the element from zero at the interface (3). The further item (4) is a cloth impregnated by the plastics material of the foam body so as to bond it to the body. A metal foil (5) can be optionally bonded as a backing to the impregnated cloth (4).
Patent NZ-524341-A (NZ)
Title: Anti bandit shutter
Inventor: CARDINAL MIKE
IPC: E06B9/06
Filed: 2001-10-16
Abstract: An "antibandit" shutter comprising a closed frame made up of a lower housing (1), an upper head (3) and two side mullions (not shown) defining a space which can be opened or closed wherein said opening or closing is effected by a plurality of elongate slats adapted (4) to move from a retracted position within the confines of said lower housing to an expanded and raised position substantially closing off said space wherein said slats are guided along the mullions of said frame by a raising means comprising a plurality of crossed first and second lever arms in the form of a lazy tongs mechanism wherein said first lever arms are formed by the edges of said slats and said second lever arms are formed from slave levers (7).
Patent NZ-525725-A (NZ)
Title: Medical plaster with piezoelectric unit
Inventor: ORTEN BIRGER
IPC: A61B17/00
Filed: 2001-10-15
Abstract: A piezoelectric unit (4), preferably a piezoelectric foil, is arranged in a medical plaster unit (13) for therapeutic or stimulating influence of body tissue in an area underneath the plaster unit. The plaster unit may be equipped with a battery (11) and a microcircuit (2) for delivering voltage pulses or oscillations to the piezo unit (4). The plaster unit (13) can possibly be used as part of a system of several plaster units (13) that are activated synchronously to influence one and the same tissues area.
Patent NZ-526143-A (NZ)
Title: Process for making substituted 8-arylquinolinium benzenesulfonate
Inventor: DESMOND RICHARD
IPC: A61P37/06
Filed: 2001-12-14
Abstract: A method of forming a reaction product mixture substantially containing a substituted 8-aryl quinolinium benzenesulfonate of compound (I), said method comprising reacting an aldehyde with an oxadiazole in the presence of an effective amount of a basic initiator such a piperidine.
Patent NZ-528016-A (NZ)
Title: Method of cleaning dairy pipelines using enzyme pretreatment
Inventor: MONKEN ALAN R
IPC: C11D3/20
Filed: 2001-10-12
Abstract: A method of removing soils including prtoeinaceous and fat contaminants from a surface comprising the steps of; initially contacting said surface with a first aqueous use dispersion including an enzyme fractions, said enzyme fraction consisting essentially of a protease enzyme; and thereafter contacting said surface with a second aqueous use dispersion including an acid and a surfactant. The first aqueous dispersion may include a polyol such as an alkylene glycol, glycerine, sorbitol or mannitol; the second aqueous use dispersion may include an acid selected from the group consisting of phosphoric, sulfuric, lactic, octanoic, hydrochloric, citric, hydroxyacetic, sulfamic, decanoic, propionic or nonanoic acids.
Patent NZ-536331-A (NZ)
Title: Compounds and method for coating surfaces of medical devices such as stents in a haemocompatible manner
Inventor: HORRES ROLAND
IPC: A61K31/436
Filed: 2003-04-15
Abstract: The disclosure relates to oligo- and polysaccharides containing the sugar structural element N-acylglucosamine or N-acylgalactosamine, in addition to the use thereof for producing haemocompatible surfaces and to methods for coating surfaces in a haemocompatible manner with said oligo- and polysaccharides, which constitute the common biosynthetic precursor substances of heparin, heparan sulphates and chitosan. The disclosure also relates to methods for producing the oligo- and/or polysaccharides, in addition to diverse application options involving haemocompatible surfaces. The disclosure specifically relates to the use of the oligo- and/or polysaccharides on stents involving at least one haemocompatible coating that has been applied according to the disclosure and that contains an anti-proliferative, anti-inflammatory and/or athrombogenic active ingredient, to methods for producing said stents and to the use of the latter for preventing restenosis.
Patent NZ-536544-A (NZ)
Title: Method for assembling/dismounting components of a wind power plant
Inventor: WOBBEN ALOYS
Filed: 2003-05-23
Abstract: A wind power installation having at least one cable passage means for passing through a hauling cable from a winch and a method of fitting/removing components of a wind power installation comprising laying a hauling cable from the winch to at least one deflection roller and further to the component to be fitted/removed, attaching the hauling cable to the component, and releasing and letting down or pulling up and fixing the component.
Patent NZ-537979-A (NZ)
Title: N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists useful for the treatment of diabetes
Inventor: BINGGELI ALFRED
IPC: C07D417/06
Filed: 2003-09-04
Abstract: N-substituted-1H-indol-5-propionic acid compounds of formula (I), pharmaceutically acceptable salts and esters thereof, as well as a process for their preparation are disclosed, wherein R1 to R8, A, A1 and n are as defined in the specification. These compounds can be used in the form of pharmaceutical preparations as PPAR agonists that are suitable in the treatment of diseases which are modulated by PPARalpha and PPARgamma agonists, and are particularly suitable for treating non-insulin dependent diabetes mellitus.
Patent NZ-540047-A (NZ)
Title: Use of combination consisting of rapamycin 42-ester with CCI-779, 5-fluorouracil and/or gemcitabine and optionally leucovorin and/or levofolinate for treating a neoplasm
Inventor: GIBBONS JAMES JOSEPH
IPC: A61K31/4965
Filed: 2002-04-05
Abstract: Use of a combination of rapamycin 42 ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid [CCI-779]; a compound selected from 5-fluorouracil and gemcitabine; and optionally a biochemical modifying agent selected from leucovorin and levofolinate in the preparation of a medicament for treating a neoplasm in a human.
Patent NZ-544355-A (NZ)
Title: Ventilated sanitary plumbing systems
Inventor: MONK KEVIN MARK
IPC: E03C1/22
Filed: 2004-07-01
Abstract: A system for forcibly ventilating a multi-story building connected to a main sewer line (15) includes at least one generally vertical sanitary stack (10) in gaseous communication adjacent the top thereof with atmosphere and adjacent the bottom thereof with a ventilating pipe (16). The ventilating pipe (16) is in gaseous communication with each stack (10) (below the lowermost sanitary inlet to the stack) for receiving the gaseous content from adjacent the bottom thereof. A stack fan (21) in gaseous communication with each stack (10) adjacent the top thereof forcibly and continuously blows air down the stack (10) to the ventilating pipe (16), and a pipe fan (17) in gaseous communication with the ventilating pipe (16) adjacent the exhaust end thereof forcibly and continuously exhausts off the gaseous content of the ventilating pipe (16) to atmosphere at a location remote from the stacks (10).
Patent NZ-548583-A (NZ)
Title: New quaternized quinuclidine esters
Inventor: FERNANDEZ FORNER MARIA DOLORS
IPC: A61K31/439
Filed: 2005-03-10
Abstract: Disclosed is a quaternized quinuclidine ester of formula (I): wherein the substituents are defined in the specification and X- represents a pharmaceutically acceptable anion of a mono or polyvalent acid; provided that the group B-(CH2)n-A-(CH2)m- is not a linear C1-4 alkyl group and further provided that the compound is not one of: 1-Allyloxycarbonylmethyl-3-(2-hydroxy-2,2-di-thiophen-2-yl-acetoxy)-1-azonia-bicyclo- [2.2.2]octane; and 1-carboxymethyl-3-(2-hydroxy-2,2-di-thiophen-2-yl-acetoxy)-1-azonia-bicyclo[2.2.2]octane. Also disclosed is a process for producing said esters, pharmaceutical compositions comprising said esters, the use of the ester in the manufacture of a medicament for the treatment of respiratory, urological or gastrointestinal disease or disorder and a combination product comprising said ester.
Patent NZ-550935-A (NZ)
Title: Low-calorie whole-grain cereal bar
Inventor: COLEMAN EDWARD C
IPC: A23L33/20
Filed: 2006-10-31
Abstract: Provided is a low-calorie whole grain cereal bars that includes whole grain and binder in amounts effective for providing a cereal bar with at least about 15 weight % or more whole grain, about 35 weight % or more of a binder, at least about 5 weight % or more of a compound coating, wherein the cereal bar is effective for providing at least about 5 weight % or more protein and fiber, and 120 or less calories per 28 gram bar as well as having a water activity of about 0.4 to 0.6. The cereal bars are low in calories but still provide a good source of whole grain and fiber while maintaining an acceptable taste, organoleptic properties and long shelf-life.
Patent NZ-553415-A (NZ)
Title: Barb configurations for barbed sutures
Inventor: LEUNG JEFFERY C
IPC: A61B17/08
Filed: 2003-09-29
Abstract: A barbed suture for connecting human or animal tissue, the suture comprising (a) an elongated body having a first end, a second end and a diameter and (b) a plurality of barbs projecting from the body, each barb facing in a direction and being adapted for resisting movement of the suture, when in tissue, in an opposite direction from the direction in which the barb faces, wherein the barbs have a configuration comprising an arcuate barb base.
Patent NZ-554778-A (NZ)
Title: Method of manufacturing a mixed plastic film by passing the plastics through at least one screen
Inventor: RASMUSSEN OLE-BENDT
IPC: B29C48/10
Filed: 2005-11-03
Abstract: A method and apparatus for forming a thermoplastic sheet is disclosed. The sheet is composed of at least two polymers that are coaxially introduced into a chamber and mixed together using at least one screen (301) that force the polymers to be divided into ribbons. The alloy of polymers is then forced through a small gap and stretched to make a film. There may be more than one screen (302) in the process, which follows the first (301), again dividing the alloy into ribbons but with a different orientation to the first (301) to improve flow shear. The relative size and of the apertures (303, 304) and interconnecting portions in the screens are important to the effectiveness of the manufacture by promoting fine fibrils of material in the alloy, each being one polymer surrounded by the other. This promotes efficient and fine expansion of an expansion agent added to the alloy.
Patent NZ-561463-A (NZ)
Title: Cable management bar and patch panel
Inventor: CLARK GORDON P
IPC: G02B6/44
Filed: 2006-03-29
Abstract: A cable management member 150 for a telecommunications patch panel, the cable management member comprising a horizontal cable bar 392 including a first bar end and a second bar end, and a first side member 482 and a second side member 484, the first side member 482 being coupled to the first bar end, the second side member 484 being coupled to the second bar end, and each of the first and second side members including first and second protrusions extending toward an opposite one of the first or second side members, the first and second protrusions defining a space there between, wherein the first and second protrusions of each of the first and second side members 482 484 form a first pair of protrusions, and wherein each of the first and second side members 482 484 further comprises a second pair of protrusions, and wherein each of the first and second side members 482 484 includes a main body, a first finger 490 491 including the first pair of protrusions, and a second finger 492 493 including the second pair of protrusions, and wherein the main body and the first and second fingers form a C-shape 494 495.
Patent NZ-562947-A (NZ)
Title: A barrier system with upper and lower railing and elongate bands as U shaped elements between railings able to be tensioned individually
Inventor: NAPIER DONALD STEWART
IPC: E04F11/18
Filed: 2006-04-04
Abstract: A barrier an upper railing (102) and a lower railing (103), and a plurality of bands such as wires each with two substantially vertical portions (118) which are positioned to be parallel each end anchored at a position which is spaced apart the position of one end being different from the position of the other end, one end being secured to a one of the railings and the other end being secured to the same railing and there being a tightening arrangement which also provides a spreader that is adapted to effect tensioning of the respective wire independently of the other wires.
Patent NZ-572632-A (NZ)
Title: Angular discrete adjustment of CPAP facial mask forehead support
Inventor: KWOK PHILIP RODNEY
IPC: A61M16/08
Filed: 2000-02-11
Abstract: A continuous positive airway pressure mask for use in positive pressure airway therapy includes a mask shell 17 with a cushion 19 and a joining member 14, and a forehead support 10 including a frame 12 movably mounted to the joining member to allow angular adjustment 31 between the mask frame and the forehead support. In the several embodiments disclosed the forehead support frame and mask frame joining member are provided with inter-engaging tongue and groove elements 34, 40 that can be disengaged and re-engaged to set the angular orientation between the mask frame and the forehead support into one of a plurality of discrete orientations. (62) Divided Out of 513052
Patent NZ-573407-A (NZ)
Title: Ob fold domains
Inventor: ARCUS VICKERY LAURENCE
IPC: C07H21/00
Filed: 2007-05-25
Abstract: Disclosed is an isolated modified OB-fold domain, obtained from a naturally occurring OB-fold domain, wherein said naturally occurring OB-fold domain has not been genetically engineered, and falls within the Pfam database wherein said modified OB-fold domain comprises at least four modified amino acid residues including: a.) At least one modified amino acid residue in a beta strand of the OB-fold domain binding face as compared to the naturally occurring OB-fold domain, or b.) At least one modified amino acid residue in a beta strand of the OB-fold domain binding face and at least one modified amino acid residue in a strand of the OB-fold domain loop region, or c.) At least one modified amino acid residue in a strand of the OB-fold domain loop region, And wherein said modified OB-fold domain is soluble and has altered binding characteristics as compared to the naturally occurring OB-fold domain. Further disclosed is a method of obtaining said modified OB-fold domain and a method for producing a library of modified OB-fold domain proteins.
Patent NZ-579056-A (NZ)
Title: 5-[3-(3-Hydroxy-phenoxy} -azetidin-1-yl]-5-methyl-2,2-diphenyl-hexanoic acid amide hydrochloride salt
Inventor: GLOSSOP PAUL ALAN
IPC: C07D205/04
Filed: 2008-03-06
Abstract: Disclosed is the hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenyl hexanamide. Further disclosed is a pharmaceutical composition comprising at least an effective amount of 5-[3-(3-hydroxy-phenoxy} -azetidin-1-yl]-5-methyl-2,2-diphenyl-hexanoic acid amide hydrochloride salt for use in the treatment of diseases, disorders, and conditions such as chronic or acute bronchoconstriction, chronic bronchitis, small airways obstruction, and emphysema, obstructive or inflammatory airways diseases, bronchitis, asthma, acute lung injury or bronchiectasis.
Patent NZ-580400-A (NZ)
Title: A massage device comprising an over-pressure sensor and applicator
Inventor: PILLER NEIL BRENTON
IPC: A61H23/00
Filed: 2008-03-25
Abstract: A massage device (10) comprising a handle (11), an applicator head (12), a vibratory source and an over-pressure sensor an indicator is disclosed. The applicator head (12) projects from the handle (11) and a vibratory source is adapted to deliver vibration to the applicator head (12). The applicator head (12) is coupled to the handle (11) and adapted to roll over a surface being treated.
Patent NZ-589531-A (NZ)
Title: Use of histamine H4 antagonist for the treatment of post-operative tissue adhesions after surgical procedures
Inventor: THURMOND ROBIN L
IPC: C07K16/28
Filed: 2009-06-11
Abstract: The disclosure relates to the use of a histamine H4 receptor antagonist in the preparation of a medicament for the inhibition of post-operative adhesion formation in a body between tissue surfaces in a body cavity having been subjected to a surgical procedure, which involve administering a histamine H4 receptor antagonist, systemically, directly to tissue surfaces in the body cavity, or both, and to delivery vehicles and compositions suitable for use for local, non-systemic administration of a drug to the body and directly to tissue within a body cavity having been subjected to a surgical procedure, wherein the medicament is formulated for systemic administration and wherein the at least one histamine H4 receptor antagonist is selected from the group consisting of:(a) benzoimidazolyl and benzoxazolyl amides and thioamides; (b) 8-membered bicyclic aromatic amides and thioamides; (c) 9-membered bicyclic aromatic amides, thioamides, and imides;(d) indolyl and benzimidazolyl pyrrolidinyl amides; pharmaceutically acceptable salts, hydrates, solvates and mixtures of any of said histamine H4 receptor antagonists.
Patent NZ-590998-A (NZ)
Title: A method for generating a personal/individual health record
Inventor: HASAN MALIK M
IPC: G16H10/60
Filed: 2006-07-31
Abstract: A method for generating a personal/individual health record is disclosed. The method comprising a personal health record system server performing the steps: (a) enrolling a patient in a health plan of a payor,; (b) initially establishing a communication link between a personal health record (PHR) system and the payor; (c) receiving payor claims data by the personal health record system server regarding the patient from the payor via the communication link; (d) analyzing at the PHR system server the payor claims data to determine which portion of the payor claims data is encounter data comprising at least one of a diagnosis, a treatment, a medication, a procedure of the patient, a history of office visits with one or more of the health care providers, and duration of office visits; (e) translating at the PHR system server the encounter data into at least one universal health care concept code; (f) creating at the PHR system server a personal/individual health record of the patient by storing one or more entries into the personal/individual health record based on the encounter data and associating the universal health care concept code with each entry; (g) organizing at the PHR system server the personal/individual health record by grouping together entries in the personal/individual health record as related based on the universal health care concept code associated with the entries; (h) subsequent to steps (a), (b), (c), (d), (e) and (f), establishing a communication link between the personal health record system and the patient, wherein the personal/individual health record is viewable by the patient via the communication link; and (i) subsequent to steps (a), (b), (c), (d), (e) and (f), supplementing the personal/individual health record with health-related data regarding the patient from one or more of the health care providers; the method further comprises establishing an access list for a user capable of accessing the personal/individual health record and adjusting the access list based on selections received by the personal health record system from the patient via the Internet; and the method further comprising providing limited access to the personal/individual health record based on a positive identification of a user as a health care provider and preparing an audit record indicative of each data element in the personal/individual health record that the user accesses.
Patent NZ-594353-A (NZ)
Title: Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor
Inventor: GHARBAOUI TAWFIK
IPC: A61K31/415
Filed: 2007-05-17
Abstract: Disclosed are processes for preparing phenyl-pyrazoles of Formula (I) as outlined in schemes II and III as shown and salts and pharmaceutical compositions thereof, useful as modulators of 5-HT2A serotonin receptor activity. Also disclosed are intermediates used in the processes, and their preparation. Further disclosed are crystalline forms of 5-HT2A serotonin receptor modulators, compositions thereof and methods of using the same.
Patent NZ-599158-A (NZ)
Title: Closure means for pipe
Inventor: DICKINSON ROSS
IPC: F16L55/17
Filed: 2010-10-15
Abstract: 599158 A closure for containing fluid leaking from a ruptured pipe is disclosed. The device comprises first (12) and second (14) housing members connected by a hinge (16). When placed on the surface of a pipe the closure defines an enclosed cavity between the housing members and the pipe. A fastening clasp is coupled to the housing operable to hold the first and second housing members in sealed engagement with the pipe. The fastening means comprises a clasp arm (60) coupled to the second housing member (14) operable to engage with clasp arm retaining lips (51a) on the first housing member (12). The closure means has an initial closed position (shown) which allows the closure means to be moved along the length of the pipe and can subsequently be fastened to the sealed closed position (see Fig. 5c).
Patent NZ-600837-A (NZ)
Title: 1,3,4-oxadiazole-2-carboxamide compound
Inventor: AKIYAMA YASUTO
IPC: A61K31/4545
Filed: 2010-12-28
Abstract: 600837 Disclosed is a 1,3,4-oxadiazole-2-carboxamide compound which has STAT3 inhibitory activity and is useful as an anticancer agent. Specifically disclosed is a 1,3,4-oxadiazole-2-carboxamide compound represented by formula (I) or a pharmacologically acceptable salt thereof. (In the formula, Ar represents a furyl group or the like; R1 represents a hydrogen atom or the like; and -X-Y represents a diaryl group such as a biphenyl group.) Specific embodiments of the compound include the following: N-[5-(2-furyl)-1,3,4-oxadiazol-2-yl]-3-biphenylcarboxamide; N-[5-(2-furyl)-1,3,4-oxadiazol-2-yl]-3-(1-methyl-5-indolinyl)benzenecarboxamide; 4’’-ethoxy-N-[5-(2-furyl)-1,3,4-oxadiazol-2-yl]-3-(p-terphenyl)carboxamide; and N-[5-(3-methyl-2-thienyl)-1,3,4-oxadiazol-2-yl]-5-phenyl-2-piperidino-7-thiazolo[4,5-b]pyridinecarboxamide.